<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd"> 
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//Springer-Verlag//DTD A++ V2.4//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName A++V2.4.dtd?><?SourceDTD.Version 2.4?><?ConverterInfo.XSLTName springer2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">Hum Genomics</journal-id><journal-id journal-id-type="iso-abbrev">Hum. Genomics</journal-id><journal-title-group><journal-title>Human Genomics</journal-title></journal-title-group><issn pub-type="ppub">1473-9542</issn><issn pub-type="epub">1479-7364</issn><publisher><publisher-name>BioMed Central</publisher-name><publisher-loc>London</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">6907335</article-id><article-id pub-id-type="publisher-id">245</article-id><article-id pub-id-type="doi">10.1186/s40246-019-0245-z</article-id><article-categories><subj-group subj-group-type="heading"><subject>Primary Research</subject></subj-group></article-categories><title-group><article-title>Downregulation of miR-542-3p promotes osteogenic transition of vascular smooth muscle cells in the aging rat by targeting BMP7</article-title></title-group><contrib-group><contrib contrib-type="author" equal-contrib="yes"><name><surname>Liu</surname><given-names>Huan</given-names></name><xref ref-type="aff" rid="Aff2">2</xref><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author" equal-contrib="yes"><name><surname>Wang</surname><given-names>Hongwei</given-names></name><xref ref-type="aff" rid="Aff5">5</xref></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Yang</surname><given-names>Sijin</given-names></name><address><email>ysjimn@sina.com</email></address><xref ref-type="aff" rid="Aff4">4</xref></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Qian</surname><given-names>Dehui</given-names></name><address><email>doctorqiandehui@163.com</email></address><xref ref-type="aff" rid="Aff1">1</xref></contrib><aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 1762 4928</institution-id><institution-id institution-id-type="GRID">grid.417298.1</institution-id><institution>Department of Cardiology, Second Hospital Affiliated to the Army Medical University, </institution><institution>Xinqiao Hospital, </institution></institution-wrap>Chongqing, 400037 China </aff><aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0000 8877 7471</institution-id><institution-id institution-id-type="GRID">grid.284723.8</institution-id><institution>The Precision Medicine Institute, The Third Affiliated Hospital, </institution><institution>Southern Medical University, </institution></institution-wrap>Guangzhou, 510150 Guangdong China </aff><aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="GRID">grid.488387.8</institution-id><institution>Department of Orthopaedics, </institution><institution>The Second Affiliated Hospital of Southwest Medical University, </institution></institution-wrap>Lu Zhou, 646000 Sichuan China </aff><aff id="Aff4"><label>4</label><institution-wrap><institution-id institution-id-type="GRID">grid.488387.8</institution-id><institution>Department of Cardiology and Neurology, </institution><institution>The Second Affiliated Hospital of Southwest Medical University, </institution></institution-wrap>184 Chunhui Street, Lu Zhou, 646000 Sichuan China </aff><aff id="Aff5"><label>5</label>Department of Orthopedics, General Hospital of Shenyang Military Area Command of Chinese PLA, Shenyang, 110016 Liaoning China </aff></contrib-group><pub-date pub-type="epub"><day>11</day><month>12</month><year>2019</year></pub-date><pub-date pub-type="pmc-release"><day>11</day><month>12</month><year>2019</year></pub-date><pub-date pub-type="collection"><year>2019</year></pub-date><volume>13</volume><elocation-id>67</elocation-id><history><date date-type="received"><day>16</day><month>6</month><year>2019</year></date><date date-type="accepted"><day>17</day><month>10</month><year>2019</year></date></history><permissions><copyright-statement>&#x000a9; The Author(s). 2019</copyright-statement><license license-type="OpenAccess"><license-p><bold>Open Access</bold>This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p></license></permissions><abstract id="Abs1"><sec><title>Background</title><p id="Par1">Aging is believed to have a close association with cardiovascular diseases, resulting in various pathological alterations in blood vessels, including vascular cell phenotypic shifts. In aging vessels, the microRNA(miRNA)-mediated mechanism regulating the vascular smooth muscle cell (VSMC) phenotype remains unclarified. MiRNA microarray was used to compare the expressions of miRNAs in VSMCs from old rats (oVSMCs) and young rats (yVSMCs). Quantitative reverse transcription real-time PCR (qRT-PCR) and small RNA transfection were used to explore the miR-542-3p expression in oVSMCs and yVSMCs <italic>in vitro</italic>. Calcification induction of yVSMCs was conducted by the treatment of &#x003b2;-glycerophosphate (&#x003b2;-GP). Alizarin red staining was used to detect calcium deposition. Western blot and qRT-PCR were used to investigate the expression of the smooth muscle markers, smooth muscle 22&#x003b1; (SM22&#x003b1;) and calponin, and the osteogenic markers, osteopontin (OPN), and runt-related transcription factor 2 (Runx2). Lentivirus was used to overexpress miR-542-3p and bone morphogenetic protein 7 (BMP7) in yVMSCs. Luciferase reporter assay was conducted to identify the target of miR-542-3p.</p></sec><sec><title>Results</title><p id="Par2">Compared with yVSMCs, 28 downregulated and 34 upregulated miRNAs were identified in oVSMCs. It was confirmed by qRT-PCR that oVSMC expressed four times lower miR-542-3p than yVSMCs. Overexpressing miR-542-3p in yVSMCs suppressed the osteogenic differentiation induced by &#x003b2;-GP. Moreover, miR-542-3p targets BMP7 and overexpressing BMP7 in miR-542-3p&#x02013;expressing yVSMCs reverses miR-542-3p&#x02019;s inhibition of osteogenic differentiation.</p></sec><sec><title>Conclusions</title><p id="Par3">miR-542-3p regulates osteogenic differentiation of VSMCs through targeting BMP7, suggesting that the downregulation of miR-542-3p in oVSMCs plays a crucial role in osteogenic transition in the aging rat.</p></sec></abstract><kwd-group xml:lang="en"><title>Keywords</title><kwd>Mir-542-3p</kwd><kwd>Vascular smooth muscle cells</kwd><kwd>Osteogenic differentiation</kwd><kwd>Aging</kwd></kwd-group><funding-group><award-group><funding-source><institution>the Natural National Science Foundation of China</institution></funding-source><award-id>81601232</award-id><principal-award-recipient><name><surname>Qian</surname><given-names>Dehui</given-names></name></principal-award-recipient></award-group></funding-group><funding-group><award-group><funding-source><institution>Chongqing Research Program of Basic Research and Frontier Technology</institution></funding-source><award-id>cstc2016jcyjA1637</award-id><principal-award-recipient><name><surname>Qian</surname><given-names>Dehui</given-names></name></principal-award-recipient></award-group></funding-group><funding-group><award-group><funding-source><institution>Sichuan Science and Technology Program</institution></funding-source><award-id>2018JY0402</award-id><principal-award-recipient><name><surname>Liu</surname><given-names>Huan</given-names></name></principal-award-recipient></award-group></funding-group><funding-group><award-group><funding-source><institution>Special Fund for High-level Talents (Chen Chen Team) of the People's Government of Luzhou-Southwestern Medical University</institution></funding-source><award-id>Chen Chen team</award-id><principal-award-recipient><name><surname>Liu</surname><given-names>Huan</given-names></name></principal-award-recipient></award-group></funding-group><custom-meta-group><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#x000a9; The Author(s) 2019</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1"><title>Background</title><p id="Par4">Aging is believed to have a close association with cardiovascular diseases [<xref ref-type="bibr" rid="CR24">24</xref>]. In elderly patients, the outcomes of vascular angioplasty and stenting are poorer than those in younger patients [<xref ref-type="bibr" rid="CR3">3</xref>] and also with a fairly higher risk of complication [<xref ref-type="bibr" rid="CR10">10</xref>, <xref ref-type="bibr" rid="CR29">29</xref>]. Vascular aging causes various pathological alterations in blood vessels, including chronic inflammation, vascular cell phenotypic shifts, and structural modifications, which lead to remodeling of the vascular wall with increased thickness and stiffness and drive arteriosclerosis and atherosclerosis [<xref ref-type="bibr" rid="CR16">16</xref>].</p><p id="Par5">Vascular smooth muscle cells (VSMCs) are contractile cells found in blood vessels and express smooth muscle markers, including smooth muscle &#x003b1;-actin (SM &#x003b1;-actin), smooth muscle 22&#x003b1; (SM22&#x003b1;), and calponin. VSMCs are not terminal differentiated cells, which can switch from the contractile phenotype to the synthetic phenotype in response to local cues and give rise to the development of aberrant remodeling of vessels [<xref ref-type="bibr" rid="CR7">7</xref>]. Increasing evidence indicates that aging is a crucial factor promoting the phenotypic shift of VSMCs and results in aging-related deterioration of blood vessels [<xref ref-type="bibr" rid="CR17">17</xref>, <xref ref-type="bibr" rid="CR25">25</xref>]. The dedifferentiation of VSMCs into osteoblast-like cells has been demonstrated to be associated with vascular calcification in the vessel wall [<xref ref-type="bibr" rid="CR7">7</xref>]. The osteogenic transition of VSMCs is accompanied by the gain of osteogenic markers, such as runt-related transcription factor 2 (Runx2), osteopontin (OPN), and alkaline phosphatase [<xref ref-type="bibr" rid="CR7">7</xref>]. The triggers of the osteogenic transition of VSMCs have been extensively studied, and many risk factors are recognized, including the loss of calcification inhibitors, senescence, cell death and damage, oxidative stress, mechanical stress, and mitochondrial dysfunction [<xref ref-type="bibr" rid="CR7">7</xref>]. However, in aging vasculature, the mechanism driving the osteogenic transition of VSMCs remains unclarified.</p><p id="Par6">MicroRNAs (miRNAs) are non-coding, single-stranded RNA molecules and function in RNA silencing and post-transcriptional regulation of gene expression, regulating a number of physiological and pathological processes. Within the cardiovascular system, altered miRNA expression has been found in the blood of patients [<xref ref-type="bibr" rid="CR2">2</xref>], and certain miRNAs have been found to be involved in various cardiovascular diseases, such as myocardial infarction, arrhythmias, hypertension, and atherosclerosis [<xref ref-type="bibr" rid="CR33">33</xref>]. In the vascular wall, aging is associated with endothelial dysfunction and a heterogeneous phenotypic shift of VSMCs. A number of miRNAs have been demonstrated to be associated the dysfunction of endothelial cells in aging [<xref ref-type="bibr" rid="CR13">13</xref>, <xref ref-type="bibr" rid="CR23">23</xref>, <xref ref-type="bibr" rid="CR40">40</xref>]. However, the mechanism that miRNAs affect phenotypic transition in aging VSMCs is incompletely defined.</p><p id="Par7">In the present study, the expressions of miRNAs in VSMCs from old rats (oVSMCs) and young rats (yVSMCs) were compared using miRNA microarray, and 28 downregulated and 34 upregulated miRNAs were identified in oVSMCs compared with those of the yVSMCs. We focused on miR-542-3p on the basis of microarray detection and demonstrated that miR-542-3p inhibited osteogenic transition of yVSMCs induced by &#x003b2;-glycerophosphate (&#x003b2;-GP) through targeting bone morphogenetic protein 7 (BMP7). Our study suggests that, in aging rats, the decrease in miR-542-3p expression promotes the osteogenic transition in VSMCs by targeting BMP7.</p></sec><sec id="Sec2"><title>Materials and methods</title><sec id="Sec3"><title>Cell culture</title><p id="Par8">Thoracic aortas of rats were harvested and VSMCs were isolated as previously described [<xref ref-type="bibr" rid="CR31">31</xref>]. Cells from passage 3&#x02013;5 were used for the experiments.</p></sec><sec id="Sec4"><title>Microarray analysis</title><p id="Par9">Approximate 1.5 &#x000d7; 10<sup>5</sup> cells were plated into 12-well plates precoated with collagen I (Thermo Fisher Scientific). After synchronization for 24&#x02009;h by serum starvation, VSMCs were cultivated in DMEM supplied with 10% FBS. After 2&#x02009;days, total RNA was extracted as previously described [<xref ref-type="bibr" rid="CR28">28</xref>]. Samples were labeled, hybridized, and scanned (Kang-Chen Bio-tech, Shanghai, China), and images were imported into GenePix Pro 6.0 software for grid alignment and data extraction.</p></sec><sec id="Sec5"><title>Small RNA transfection</title><p id="Par10">Approximately 2.5 &#x000d7; 10<sup>5</sup> VSMCs were plated into 6-well plates. After 24&#x02009;h, transfection was performed with 50-nM anti-miR-542-3p (yVSMCs), 50-nM pre-miR-542-3p (oVSMCs), or the associated negative controls, using Lipofectamine RNAiMAX (Invitrogen, Carlsbad, CA, USA). After 12&#x02009;h, fresh DMEM was added and RNA extraction was performed 24&#x02009;h later.</p></sec><sec id="Sec6"><title>Quantitative reverse transcription real-time PCR</title><p id="Par11">To quantify the miR-543-3p expression, 1.0&#x02009;&#x003bc;g of total RNA was reverse transcribed using a TaqMan miRNA Reverse Transcription kit (Applied Biosystems, Shanghai, China). miR-542-3p expression was measured using a miR-542-3p TaqMan microRNA assay (Applied Biosystems). The expression of miR-543-3p was quantified using the 2<sup>&#x02212;&#x00394;&#x00394;Ct</sup> relative quantification method. The relative expression levels of miR-542-3p were determined by normalizing to that of housekeeping gene U6.</p><p id="Par12">To detect the expression of smooth muscle&#x02013;related genes and calcification-related genes, quantitative real-time PCR (qRT-PCR) was conducted following the reverse transcription. The primer sequences used for SM22&#x003b1;, calponin, OPN, Runx2, and glyceraldehyde-3-phosphate dehydrogenase (GAPDH) are listed in Table <xref rid="Tab1" ref-type="table">1</xref>. The relative mRNA expressions were determined by normalizing to that of the housekeeping gene GAPDH.
<table-wrap id="Tab1"><label>Table 1</label><caption><p>Primer sequences for real-time PCR</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Genes</th><th>5&#x02032;-3&#x02032;</th><th>Primers</th><th>Product<break/>Size (bp)</th><th>Reference sequence</th></tr></thead><tbody><tr><td><italic>SM 22&#x003b1;</italic></td><td><p>Forward</p><p>Reverse</p></td><td><p>CCCGCCCTCCATGGTCTTCAAG</p><p>GCCAAACTGCCCAAAGCCATTAC</p></td><td>165</td><td>NM_031549.1</td></tr><tr><td><italic>Calponin</italic></td><td><p>Forward</p><p>Reverse</p></td><td><p>CGGGCACCAAGCGGCAGATCT</p><p>CCGGGGTCAGGCAGTACTTGGGA</p></td><td>165</td><td>NM_031747.1</td></tr><tr><td><italic>OPN</italic></td><td><p>Forward</p><p>Reverse</p></td><td><p>CATCAGAGCCACGAGTTTCA</p><p>TCAGGGCCCAAAACACTATC</p></td><td>274</td><td>NM_012881.2</td></tr><tr><td><italic>Runx2</italic></td><td><p>Forward</p><p>Reverse</p></td><td><p>CAGACCAGCAGCACTCCATA</p><p>CAGCGTCAACACCATCATTC</p></td><td>178</td><td>NM_001278483.1</td></tr><tr><td><italic>GAPDH</italic></td><td><p>Forward</p><p>Reverse</p></td><td><p>AAGTTCAACGGCACAGTCAAGG</p><p>CGCCAGTAGACTCCACGACATA</p></td><td>139</td><td>NM_017008.4</td></tr></tbody></table></table-wrap></p></sec><sec id="Sec7"><title>Luciferase reporter construction and luciferase activity assay</title><p id="Par13">BMP7 mRNA was predicted to be a target of miR-542-3p by the use of TargetScan and Miranda. The 3&#x02032;-UTR of BMP7 containing the predicted targeting site for miR-542-3p was synthesized (BMP7 WT). A mutated sequence was synthesized as well by changing 2 nucleotides (BMP7 MUT). The 3&#x02032;-UTR of the luciferase reporter containing the BMP7 WT sequence or the BMP7 MUT sequence was inserted into the pmirGLO vector (Promega, Beijing, China). The pre-miR-542-3p was synthesized and inserted in the pSilencer4.1 vector (pSilencer4.1-miR-542-3p, Invitrogen).</p><p id="Par14">For the luciferase assay, about 10<sup>5</sup> HEK293 cells were seeded into 12-well plates. Cells were then co-transfected with BMP7 WT vector or BMP7 MUT vector, and pSilencer4.1-miR-542-3p or pSilencer4.1 empty vector. Luciferase activity assay was performed after 24&#x02009;h, using the Dual-Luciferase Reporter System (Promega).</p></sec><sec id="Sec8"><title>Lentivirus construction and transduction</title><p id="Par15">Lentivirus was constructed and transduced into yVSMCs to overexpress miR-542-3p or BMP7. Briefly, the coding sequences of target cDNAs were subcloned into the pCDH vector and co-transfected into HEK293T cells with psPAX2 and pMD2.G using Lipofectamine 2000 (Invitrogen). Virus particles were collected from the supernatant 48&#x02009;h after transfection and used for the infection of yVSMCs. The infected yVSMCs were incubated in growth medium in the presence of puromycin for stable selection. Cells infected by virus particles generated by empty pCDH vector were used as control.</p></sec><sec id="Sec9"><title>Calcification induction and Alizarin red staining</title><p id="Par16">To induce calcification, yVSMCs stably expressing miR-542-3p were cultivated in growth medium supplemented with 10-nM &#x003b2;-GP (Sigma-Aldrich; Merck KGaA, Darmstadt, Germany). After a 7-day incubation, yVSMCs were fixed with 95% ethanol for 30&#x02009;min at room temperature and stained with 1% Alizarin red (Sigma-Aldrich, Merck KGaA) for 15&#x02009;min. After washing, the calcium deposition was photographed under an inverted phase-contrast microscope (Olympus, Tokyo, Japan). The calcium deposition was quantified by dye elution as previously described [<xref ref-type="bibr" rid="CR9">9</xref>].</p></sec><sec id="Sec10"><title>Western blot</title><p id="Par17">VSMCs lysis was conducted using RIPA lysis buffer (Beyotime, Shanghai, China) supplied with 1% protease inhibitors. The proteins were separated by electrophoresis and transferred onto PVDF membranes by electroblotting for 3&#x02009;h at 150&#x02009;mA. Then, the membranes were blocked for 1&#x02009;h at room temperature in Tris-buffered saline containing 0.1% Tween 20 (TBST) and 5% skim milk. The membranes were incubated with primary antibodies against BMP7 (Abcam, Cambridge, MA), SM22&#x003b1; (Abcam), calponin (Abcam), OPN (Cell Signaling Technology, Danvers, MA, USA), Runx2 (Cell Signaling Technology), and GAPDH (ZSGB-Bio, Beijing, China), and then the HRP-conjugated secondary antibody (MultiSciences, Beijing, China). Chemiluminescent signals were detected and quantified by densitometry using Quantity One Bioanalysis software (Bio-Rad).</p></sec><sec id="Sec11"><title>Statistical analysis</title><p id="Par18">Data were presented as means &#x000b1; standard deviation (SD). For the comparison of groups, Tukey&#x02019;s multiple comparisons test was used following ANOVA. <italic>P</italic> &#x0003c; 0.05 was considered statistically significant.</p></sec></sec><sec id="Sec12"><title>Results</title><sec id="Sec13"><title>miRNA expression in oVSMCs and yVSMCs</title><p id="Par19">In our experiment, 260 miRNAs were statistically analyzed using miRNA array. Our results indicated 28 downregulated and 34 upregulated miRNAs in oVSMCs when comparing with yVSMCs (Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Table S1 and S2). According to the microarray data, miR-542-3p expression was reduced 14-fold in oVSMCs. Given that the effect of miR-542-3p in VSMC senescence and its relationship with cardiovascular diseases has barely known, we focused on miR-542-3p in this study.</p><p id="Par20">To confirm the miRNA microarray data, qRT-PCR was used to explore the miR-542-3p expression levels in yVSMCs and oVSMCs. We found that miR-542-3p was four times lower expressed in oVSMCs versus that in yVSMCs (Fig. <xref rid="Fig1" ref-type="fig">1</xref>a). Furthermore, anti-miR-542-3p transfection into yVSMCs resulted in a significant downregulation of miR-542-3p expression (Fig. <xref rid="Fig1" ref-type="fig">1</xref>b), while transfection of pre-miR-542-3p into oVSMCs gave rise to a significant upregulation of miR-542-3p (Fig. <xref rid="Fig1" ref-type="fig">1</xref>c). These data suggested that miR-542-3p was abundant in yVSMCs whose expression was decreased within the senescence of VSMCs.
<fig id="Fig1"><label>Fig. 1</label><caption><p>miR-542-3p expression in yVMSCs and oVMSCs detected by qRT-PCR. <bold>a</bold> miR-542-3p expression was approximately downregulated 4-fold in oVSMCs comparing with yVSMCs. <italic>n</italic> = 3. Versus yVSMCs, *<italic>p</italic> &#x0003c; 0.05. <bold>b</bold> Transfection of anti-miR-542-3p into yVSMCs (yVSMCs+anti-miR-542-3p) significantly downregulated the miR-542-3p expression. <italic>n</italic> = 3. Versus yVSMCs and yVSMCs transfected with its associated negative control (yVSMCs+vehicle) *<italic>p</italic> &#x0003c; 0.05. <bold>c</bold> Transfection of pre-miR-542-3p into oVSMCs (oVSMCs+pre-miR-542-3p) significantly upregulated the miR-542-3p expression. <italic>n</italic> = 3. Versus oVSMCs and oVSMCs transfected with its associated negative control (oVSMC+vehicle) *<italic>p</italic> &#x0003c; 0.05</p></caption><graphic xlink:href="40246_2019_245_Fig1_HTML" id="MO1"/></fig></p></sec><sec id="Sec14"><title>miR-542-3p inhibited osteogenic transition in yVSMCs induced by &#x003b2;-GP</title><p id="Par21">To explore the effect of miR-542-3p on the osteogenic transition, miR-542-3p was overexpressed in yVSMCs using lentivirus, and the miR-542-3p-expressing cells were cultured in growth medium containing 10&#x02009;nM &#x003b2;-GP for 7&#x02009;days to induce calcification. Western blot data showed that after &#x003b2;-GP induction, the expressions of the smooth muscle markers SM22&#x003b1; and calponin were significantly higher in yVSMCs overexpressing miR-542-3p than those of yVSMCs (control) and yVSMCs infected with empty virus (vector) (Fig. <xref rid="Fig2" ref-type="fig">2</xref>a and b). After &#x003b2;-GP induction, the osteogenic markers OPN and Runx2 were expressed in control and vector yVSMCs. However, overexpressing miR-542-3p in yVSMCs decreased the OPN and Runx2 expressions induced by &#x003b2;-GP (Fig. <xref rid="Fig2" ref-type="fig">2</xref>a and b).
<fig id="Fig2"><label>Fig. 2</label><caption><p>miR-542-3p inhibited osteogenic transition in yVSMCs induced by &#x003b2;-GP. Control yVSMCs, yVSMCs infected with an empty virus vector, and yVSMCs stably expressing miR-542-3p (miR-542-3p) were induced to calcify by &#x003b2;-GP. <bold>a</bold> After 7&#x02009;days of induction, expressions smooth muscle markers (SM22&#x003b1; and calponin) and osteogenic markers (OPN and Runx2) were investigated by Western blot. GAPDH was used as loading control. <bold>b</bold> Quantification of protein expressions by densitometric analysis. <italic>n</italic> = 3. Versus control and vector yVSMCs, *<italic>p</italic> &#x0003c; 0.05 and **<italic>p</italic> &#x0003c; 0.01. <bold>c</bold> After &#x003b2;-GP induction for 7&#x02009;days, calcium deposition was detected by Alizarin red staining. <bold>d</bold> Quantification of calcium deposition. <italic>n</italic> = 3. Versus control and vector yVSMCs, **<italic>p</italic> &#x0003c; 0.01</p></caption><graphic xlink:href="40246_2019_245_Fig2_HTML" id="MO2"/></fig></p><p id="Par22">Calcium deposition assay by Alizarin red staining was performed to morphologically confirm osteogenic differentiation. After &#x003b2;-GP induction, obvious calcium nodules were observed in control and vector yVSMCs, while in miR-542-3p&#x02013;overexpressing yVSMCs, the calcium nodules were much fewer than in the other two groups (Fig. <xref rid="Fig2" ref-type="fig">2</xref>c). We further quantified the calcium deposition by eluting the Alizarin red and determining the optical density of the eluates. Consistent with the morphological data (Fig. <xref rid="Fig2" ref-type="fig">2</xref>c), these results demonstrated that the calcium deposition in miR-542-3p yVSMCs was suppressed when compared with that in control and vector yVSMCs (Fig. <xref rid="Fig2" ref-type="fig">2</xref>d). In general, these findings demonstrated that miR-542-3p overexpression could restrain the osteogenic phenotype of yVSMCs induced by &#x003b2;-GP. Thus, our results suggested that miR-542-3p might play a crucial role in regulating the osteogenic transition of VSMCs with senescence.</p></sec><sec id="Sec15"><title>miR-542-3p targeted BMP7</title><p id="Par23">BMPs were discovered by their capability to induce bone formation. To explore the potential targets of miR-542-3p involved in osteogenic transition of VSMCs, Targetscan and Miranda databases were used, and BMP7 was identified as a potential target. Therefore, BMP7 expression and its correlation with miR-542-3p were examined in yVSMCs induced by &#x003b2;-GP. As shown in Fig. <xref rid="Fig3" ref-type="fig">3</xref>a and b, after 7&#x02009;days of induction by &#x003b2;-GP, yVSMCs overexpressing miR-542-3p expressed a significantly lower level of BMP7 than control yVSMCs and yVSMCs infected with empty virus, suggesting that miR-542-3p could suppress BMP7 expression in yVSMCs induced by &#x003b2;-GP, and that BMP7 is a potential target of miR-542-3p.
<fig id="Fig3"><label>Fig. 3</label><caption><p>miR-542-3p targeted BMP7. <bold>a</bold> After 7&#x02009;days of induction by &#x003b2;-GP, the protein expression of BMP7 was detected by Western blot. yVSMCs overexpressing miR-542-3p (miR-542-3p) expressed an obviously lower level of BMP7 than control yVSMCs and yVSMCs infected with an empty virus vector. <bold>b</bold> Quantification of BMP7 expression by densitometric analysis. The relative expression of BMP7 was normalized to that of GADPH. <italic>n</italic> = 3. Versus control and vector group, **<italic>p</italic> &#x0003c; 0.01. <bold>c</bold> BMP7 3&#x02032;-UTR constructs used in luciferase assay. <bold>d</bold> Effect of miR-542-3p overexpression on a dual luciferase reporter plasmid containing the BMP7 3&#x02032;-UTR was analyzed. HEK293T cells were co-transfected with either the BMP7 WT or BMP7 MUT or an empty vector and miR-542-3p (miR-542-3p). Renilla luciferase activity was quantified and normalized to firefly luciferase activity. <italic>n</italic> = 3. Versus vector group, **<italic>p</italic> &#x0003c; 0.01</p></caption><graphic xlink:href="40246_2019_245_Fig3_HTML" id="MO3"/></fig></p><p id="Par24">To confirm whether BMP7 is targeted by miR-542-3p, a luciferase reporter assay was performed using BMP7 3&#x02032;-UTR constructs (Fig. <xref rid="Fig3" ref-type="fig">3</xref>c). The 3&#x02032;-UTR of the luciferase reporter was generated containing BMP7 WT sequence or BMP7 MUT sequence. The luciferase assay showed that the overexpression of miR-542-3p strongly inhibited the luciferase activity in the BMP7 WT group but did not the BMP7 MUT group (Fig. <xref rid="Fig3" ref-type="fig">3</xref>d), which demonstrated that BMP7 is a direct target of miR-542-3p.</p></sec><sec id="Sec16"><title>miR-542-3p regulated osteogenic transition by targeting BMP7</title><p id="Par25">To explore whether the targeting of miR-542-3p to BMP7 regulating the osteogenic transition of VSMCs, yVSMCs stably overexpressing miR-542-3p (miR-yVSMCs) were used for transduction with BMP7-overexpressing lentivirus or control empty virus. The expression of smooth muscle markers SM22&#x003b1; and calponin was significantly downregulated by overexpressing BMP7 in miR-yVSMCs, while the mRNA expression of osteogenic markers OPN and Runx2 was strongly increased in BMP7-overexpressing miR-yVSMCs when compared with that of the control miR-yVSMCs or miR-yVSMCs transduced with control vector (Fig. <xref rid="Fig4" ref-type="fig">4</xref>a). Consistent with the mRNA expression data, the Western blot results also demonstrated that overexpressing BMP7 in miR-yVSMCs decreased the protein expression levels of the smooth muscle markers SM22&#x003b1; and calponin, and increased the protein expression levels of the osteogenic markers OPN and Runx2 (Fig. <xref rid="Fig4" ref-type="fig">4</xref>b and c).
<fig id="Fig4"><label>Fig. 4</label><caption><p>miR-542-3p regulated osteogenic transition by targeting BMP7. yVSMCs overexpressing miR-542-3p (miR-yVSMCs) were transduced with BMP7-overexpressing lentivirus or control empty virus. After 7&#x02009;days of induction by &#x003b2;-GP, the mRNA (<bold>a</bold>) and protein (<bold>b</bold>) expression levels of smooth muscle markers (SM22&#x003b1; and calponin) and osteogenic markers (OPN and Runx2) were detected. <bold>c</bold> Quantification of protein expression levels by densitometric analysis. <bold>d</bold> Calcium deposition detected by Alizarin red staining. <bold>e</bold> Quantification of calcium deposition. Control: miR-yVSMCs; Vector: miR-yVSMCs transduced with control empty virus; BMP7 overexpression: miR-yVSMCs transduced with BMP7-overexpressing lentivirus. <italic>n</italic> = 3. Versus control and vector groups, *<italic>p</italic> &#x0003c; 0.05, **<italic>p</italic> &#x0003c; 0.01</p></caption><graphic xlink:href="40246_2019_245_Fig4_HTML" id="MO4"/></fig></p><p id="Par26">Alizarin red staining was performed to examine calcium deposition. Calcium deposition was significantly higher in miR-yVSMCs overexpressing BMP7 compared with that of the control miR-yVSMCs or miR-yVSMCs transduced with control vector (Fig. <xref rid="Fig4" ref-type="fig">4</xref>d and e). Together, these results demonstrated that overexpressing BMP7 in miR-yVSMCs reversed miR-542-3p&#x02019;s suppression of the osteogenic transition of yVSMCs, suggesting that miR-542-3p regulated osteogenic transition of VSMCs via targeting BMP7.</p></sec></sec><sec id="Sec17"><title>Discussion</title><p id="Par27">In this study, by miRNA microarray, we identified 28 downregulated and 34 upregulated miRNAs in oVSMCs compared with yVSMCs. Among these miRNAs, miR-542-3p, whose expression level was 14 folds downregulated in oVSMCs, was selected for further study. Our results showed that miR-542-3p suppressed the osteogenic differentiation of yVSMCs induced by &#x003b2;-GP. BMP7 was found to be directly targeted by miR-542-3p, and overexpressing BMP7 in miR-542-3p&#x02013;expressing yVSMCs could reverse miR-542-3p&#x02019;s inhibition of osteogenic differentiation. Our findings indicated that downregulation of miR-542-3p promotes the osteogenic transition of VSMCs in the aging rat via targeting BMP7.</p><p id="Par28">Cardiovascular disease is a major cause of death worldwide and the biological mechanisms of its development remain unclear. In recent years, the roles of miRNAs in regulating cell functions have been proved in the cardiovascular system, such as cardiomyocytes, endothelial cells, fibroblasts, and smooth muscle cells [<xref ref-type="bibr" rid="CR33">33</xref>]. miRNAs are non-coding RNAs that inhibit protein translation and/or anneal to mRNAs and promote their cleavage. Accumulating reports have proved the involvement of miRNAs in pathological changes of the cardiovascular system [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR12">12</xref>, <xref ref-type="bibr" rid="CR33">33</xref>].</p><p id="Par29">Cardiovascular diseases are a prevailing issue in aging patients. Vascular senescence has a close connection with a broad spectrum of cardiovascular diseases, with the characteristics of endothelial dysfunction and phenotypic transition of smooth muscle cells, resulting in increased vascular stiffness and increased thickness of vascular walls. It has been reported that the age-associated phenotypic transition of VSMCs is a crucial contributor to vascular remodeling [<xref ref-type="bibr" rid="CR17">17</xref>, <xref ref-type="bibr" rid="CR25">25</xref>]. However, the mechanism that drives phenotypic transition of VSMCs with aging remains unclarified. In this study, using RNAs extracted from the in vitro cultured VSMCs, we explored the miRNA expression profile by microarray. Owing that rat aortas are composed of many kinds of cells, including VSMCs, endothelial cells, and fibroblasts, to avoid the contamination of RNA from endothelial cells and fibroblasts, we extracted the RNAs extracted from the in vitro cultured VSMCs instead from the aortas, which may be a drawback of our study. By microarray, we investigated miRNA expressions in yVSMCs and oVSMCs and identified 28 miRNAs downregulated in oVSMCs, including miR-196a-5p (~ 107-fold), miR-196b-5p (~ 48-fold), miR-542-3p (~ 14-fold), and miR-363-5p (~ 8-fold). miR-196a-5p and miR-196b-5p were reported to be involved in regulating cancer progression [<xref ref-type="bibr" rid="CR26">26</xref>, <xref ref-type="bibr" rid="CR27">27</xref>, <xref ref-type="bibr" rid="CR36">36</xref>, <xref ref-type="bibr" rid="CR37">37</xref>]. Thus, miR-542-3p was selected in the present study.</p><p id="Par30">miR-542-3p was previously demonstrated to be involved in osteoblast proliferation and differentiation [<xref ref-type="bibr" rid="CR14">14</xref>]; however, its function in vascular cells is unclear. In our study, inhibited expression of osteogenic markers and calcium deposition were observed in miR-542-3p-overexpressing yVSMCs, while the expression of smooth muscle markers was upregulated, indicating a pivotal role of miR-542-3p in regulating osteogenic transition of VSMCs. Certain miRNAs have been reported to induce switching of VSMCs to the synthetic phenotype, including miR-let-7&#x02009;g [<xref ref-type="bibr" rid="CR32">32</xref>], miR-132 [<xref ref-type="bibr" rid="CR5">5</xref>], miR-145 [<xref ref-type="bibr" rid="CR19">19</xref>], miR-32 [<xref ref-type="bibr" rid="CR20">20</xref>, <xref ref-type="bibr" rid="CR21">21</xref>], and miR-22 [<xref ref-type="bibr" rid="CR36">36</xref>, <xref ref-type="bibr" rid="CR37">37</xref>]; some of which, for example miR-145 and miR-32, were identified to regulate osteogenic switching of VSMCs. However, miRNAs involved in the age-associated phenotypic conversion of VSMCs have not been completely identified. miR-542-3p has been proved to suppress cancer cell growth [<xref ref-type="bibr" rid="CR20">20</xref>, <xref ref-type="bibr" rid="CR21">21</xref>, <xref ref-type="bibr" rid="CR30">30</xref>]. Our previous work showed that the downregulation of miR-542-3p promoted neointimal formation in aging rats [<xref ref-type="bibr" rid="CR28">28</xref>]. In the present study, we showed that miR-542-3p regulates the osteogenic transition of VSMCs, and with aging, downregulated miR-542-3p was associated with the calcification of the vascular wall.</p><p id="Par31">BMPs are a group of proteins originally discovered to have the capability in inducing osteogenesis and chondrogenesis. There are more than 20 members in BMP family, and some family members, especially BMP2 and BMP7, have been shown to induce osteoblast differentiation and bone formation <italic>in vivo</italic> and <italic>ex vivo</italic> [<xref ref-type="bibr" rid="CR35">35</xref>]. BMP signaling was also found to be associated with vascular diseases [<xref ref-type="bibr" rid="CR4">4</xref>, <xref ref-type="bibr" rid="CR8">8</xref>] and vascular calcification [<xref ref-type="bibr" rid="CR11">11</xref>, <xref ref-type="bibr" rid="CR38">38</xref>]. In our study, BMP7 was confirmed to be a target of miR-542-3p. Consistent with our study, it was reported that miR-542-3p suppresses osteoblast cell proliferation and differentiation by targeting BMP7 signaling [<xref ref-type="bibr" rid="CR14">14</xref>]. The miRNAs miR-22 [<xref ref-type="bibr" rid="CR22">22</xref>] and miR-22-3p [<xref ref-type="bibr" rid="CR34">34</xref>] were also demonstrated to target BMP7. Additionally, using an online database miRDB (<ext-link ext-link-type="uri" xlink:href="http://mirdb.org">http://mirdb.org</ext-link>), we predicted the potential targets of rno-miR-542-3p, and identified 328 predicted targets for miR-542-3p (Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Table S3), which could further help us to understand the role of miR-542-3p in VSMCs.</p><p id="Par32">Generally, in this study, overexpression of miR-542-3p inhibited BMP7 expression in yVSMCs and osteogenic differentiation of yVSMCs, which can be reversed by overexpressing BMP7 in miR-542-3p&#x02013;overexpressing yVSMCs, suggesting that miR-542-3p regulates osteogenic transition of VSMCs via targeting BMP7. BMP7 is extensively expressed in various tissues and is connected to the development and pathological changes of bone, renal, and ocular systems, as well as the central nervous system [<xref ref-type="bibr" rid="CR15">15</xref>]. Although BMP7 has been demonstrated to play important role in osteogenesis [<xref ref-type="bibr" rid="CR35">35</xref>], its role in the osteogenic transition of VSMCs and vascular calcification has not been well documented. Instead, some studies related BMP2 to vascular calcification by its role in regulating osteoblast differentiation of VSMCs [<xref ref-type="bibr" rid="CR6">6</xref>, <xref ref-type="bibr" rid="CR18">18</xref>, <xref ref-type="bibr" rid="CR39">39</xref>]. Thus, our study demonstrated novel signaling of BMP7, regulating the osteogenic transition of VSMCs and vascular calcification.</p></sec><sec id="Sec18"><title>Conclusions</title><p id="Par33">We demonstrated that miR-542-3p was differentially expressed in oVSMCs and yVSMCs and demonstrated that miR-542-3p overexpression prohibited BMP7 expression and osteogenic differentiation in yVSMCs induced by &#x003b2;-GP, which can be reversed by overexpressing BMP7 in miR-542-3p&#x02013;overexpressing yVSMCs. A proposed schematic diagram of miR-542-3p regulating the osteogenic transition of VSMCs in aging rats is shown in Fig. <xref rid="Fig5" ref-type="fig">5</xref>. Together, our results suggested that miR-542-3p regulates the osteogenic transition of VSMCs in aging rats by targeting BMP7. These findings are helpful for a better understanding of the role of miRNAs in regulating the osteogenic transition of VSMCs in aging.
<fig id="Fig5"><label>Fig. 5</label><caption><p>A proposed schematic diagram of miR-542-3p regulating the osteogenic transition of VSMCs in aging rats. MiR-542-3p expression is downregulated in oVSMCs. As a target of MiR-542-3p, the expression of BMP7 is upregulated which results in the osteogenic differentiation of VSMCs, suggesting the role of miR-542-3p in the vascular osteogenic transition in aging rat</p></caption><graphic xlink:href="40246_2019_245_Fig5_HTML" id="MO5"/></fig></p></sec><sec sec-type="supplementary-material"><title>Supplementary information</title><sec id="Sec19"><p>
<supplementary-material content-type="local-data" id="MOESM1"><media xlink:href="40246_2019_245_MOESM1_ESM.xls"><caption><p><bold>Additional file 1: Table S1.</bold> oVSMCs vs yVSMCs 2.0 fold upregulated miRNAs. <bold>Table S2.</bold> oVSMCs vs yVSMCs 2.0 fold downregulated miRNAs. <bold>Table S3.</bold> Predicted targets of miR-542-3p.</p></caption></media></supplementary-material>
</p></sec></sec></body><back><fn-group><fn><p><bold>Publisher&#x02019;s Note</bold></p><p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn><fn><p>Huan Liu and Hongwei Wang contributed equally to this work.</p></fn></fn-group><sec><title>Supplementary information</title><p><bold>Supplementary information</bold> accompanies this paper at 10.1186/s40246-019-0245-z.</p></sec><ack><title>Acknowledgements</title><p>Not applicable.</p></ack><notes notes-type="author-contribution"><title>Authors&#x02019; contributions</title><p>HL performed the experiment and wrote the manuscript. HW analyzed the data. SY designed the study. HL and DQ funded the study. All authors read and approved the final manuscript.</p></notes><notes notes-type="funding-information"><title>Funding</title><p>This work was supported by grants from the Natural National Science Foundation of China (No. 81601232), Chongqing Research Program of Basic Research and Frontier Technology (No. cstc2016jcyjA1637), Special Fund for High-level Talents (Chen Chen Team) of the People&#x02019;s Government of Luzhou-Southwestern Medical University, and supported by Sichuan Science and Technology Program (No. 2018JY0402).</p></notes><notes notes-type="data-availability"><title>Availability of data and materials</title><p>Not applicable.</p></notes><notes><title>Ethics approval and consent to participate</title><p id="Par34">Not applicable.</p></notes><notes><title>Consent for publication</title><p id="Par35">Not applicable.</p></notes><notes notes-type="COI-statement"><title>Competing interests</title><p id="Par36">The authors declare that they have no competing interests.</p></notes><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barwari</surname><given-names>T</given-names></name><name><surname>Joshi</surname><given-names>A</given-names></name><name><surname>Mayr</surname><given-names>M</given-names></name></person-group><article-title>MicroRNAs in cardiovascular disease</article-title><source>Journal of the American College of Cardiology</source><year>2016</year><volume>68</volume><issue>23</issue><fpage>2577</fpage><lpage>2584</lpage><pub-id pub-id-type="doi">10.1016/j.jacc.2016.09.945</pub-id><?supplied-pmid 27931616?><pub-id pub-id-type="pmid">27931616</pub-id></element-citation></ref><ref id="CR2"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bronze-Da-Rocha</surname><given-names>E</given-names></name></person-group><article-title>MicroRNAs expression profiles in cardiovascular diseases</article-title><source>BioMed Research International</source><year>2014</year><volume>2014</volume><fpage>985408</fpage><pub-id pub-id-type="doi">10.1155/2014/985408</pub-id><?supplied-pmid 25013816?><pub-id pub-id-type="pmid">25013816</pub-id></element-citation></ref><ref id="CR3"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brott</surname><given-names>TG</given-names></name><name><surname>Hobson</surname><given-names>RW</given-names></name><name><surname>Howard</surname><given-names>G</given-names></name><name><surname>Roubin</surname><given-names>GS</given-names></name><name><surname>Clark</surname><given-names>WM</given-names></name><name><surname>Brooks</surname><given-names>W</given-names></name><name><surname>Meschia</surname><given-names>JF</given-names></name></person-group><article-title>Stenting versus endarterectomy for treatment of carotid-artery stenosis</article-title><source>New England J Med</source><year>2010</year><volume>363</volume><issue>1</issue><fpage>11</fpage><lpage>23</lpage><pub-id pub-id-type="doi">10.1056/NEJMoa0912321</pub-id><pub-id pub-id-type="pmid">20505173</pub-id></element-citation></ref><ref id="CR4"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cai</surname><given-names>J</given-names></name><name><surname>Pardali</surname><given-names>E</given-names></name><name><surname>S&#x000e1;nchez-Duffhues</surname><given-names>G</given-names></name><name><surname>Ten Dijke</surname><given-names>P</given-names></name></person-group><article-title>BMP signaling in vascular diseases</article-title><source>FEBS Letters</source><year>2012</year><volume>586</volume><fpage>1993</fpage><lpage>2002</lpage><pub-id pub-id-type="doi">10.1016/j.febslet.2012.04.030</pub-id><?supplied-pmid 22710160?><pub-id pub-id-type="pmid">22710160</pub-id></element-citation></ref><ref id="CR5"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>WJ</given-names></name><name><surname>Chen</surname><given-names>YH</given-names></name><name><surname>Hsu</surname><given-names>YJ</given-names></name><name><surname>Lin</surname><given-names>KH</given-names></name><name><surname>Yeh</surname><given-names>YH</given-names></name></person-group><article-title>MicroRNA-132 targeting PTEN contributes to cilostazol-promoted vascular smooth muscle cell differentiation</article-title><source>Atherosclerosis</source><year>2018</year><volume>274</volume><fpage>107</fpage><pub-id pub-id-type="doi">10.1016/j.atherosclerosis.2018.04.030</pub-id></element-citation></ref><ref id="CR6"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Davenport</surname><given-names>C</given-names></name><name><surname>Harper</surname><given-names>E</given-names></name><name><surname>Forde</surname><given-names>H</given-names></name><name><surname>Rochfort</surname><given-names>KD</given-names></name><name><surname>Murphy</surname><given-names>RP</given-names></name><name><surname>Smith</surname><given-names>D</given-names></name><name><surname>Cummins</surname><given-names>PM</given-names></name></person-group><article-title>RANKL promotes osteoblastic activity in vascular smooth muscle cells by upregulating endothelial BMP-2 release</article-title><source>Int J Biochem Cell Biol</source><year>2016</year><volume>77</volume><issue>Part A</issue><fpage>171</fpage><lpage>180</lpage><pub-id pub-id-type="doi">10.1016/j.biocel.2016.06.009</pub-id><?supplied-pmid 27339040?><pub-id pub-id-type="pmid">27339040</pub-id></element-citation></ref><ref id="CR7"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Durham</surname><given-names>AL</given-names></name><name><surname>Speer</surname><given-names>MY</given-names></name><name><surname>Scatena</surname><given-names>M</given-names></name><name><surname>Giachelli</surname><given-names>CM</given-names></name><name><surname>Shanahan</surname><given-names>CM</given-names></name></person-group><article-title>Role of smooth muscle cells in vascular calcification: implications in atherosclerosis and arterial stiffness</article-title><source>Cardiovasc Res</source><year>2018</year><volume>114</volume><issue>4</issue><fpage>590</fpage><lpage>600</lpage><pub-id pub-id-type="doi">10.1093/cvr/cvy010</pub-id><?supplied-pmid 29514202?><pub-id pub-id-type="pmid">29514202</pub-id></element-citation></ref><ref id="CR8"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Garc&#x000ed;a de Vinuesa</surname><given-names>A</given-names></name><name><surname>Abdelilah-Seyfried</surname><given-names>S</given-names></name><name><surname>Zwijsen</surname><given-names>A</given-names></name><name><surname>Bailly</surname><given-names>S</given-names></name></person-group><article-title>BMP signaling in vascular biology and dysfunction</article-title><source>Cytokine Growth Factor Rev</source><year>2016</year><volume>27</volume><fpage>65</fpage><lpage>79</lpage><pub-id pub-id-type="doi">10.1016/j.cytogfr.2015.12.005</pub-id><?supplied-pmid 26823333?><pub-id pub-id-type="pmid">26823333</pub-id></element-citation></ref><ref id="CR9"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gregory</surname><given-names>CA</given-names></name><name><surname>Gunn</surname><given-names>WG</given-names></name><name><surname>Peister</surname><given-names>A</given-names></name><name><surname>Prockop</surname><given-names>DJ</given-names></name></person-group><article-title>An Alizarin red-based assay of mineralization by adherent cells in culture: comparison with cetylpyridinium chloride extraction</article-title><source>Analytical Biochemistry</source><year>2004</year><volume>329</volume><issue>1</issue><fpage>77</fpage><lpage>84</lpage><pub-id pub-id-type="doi">10.1016/j.ab.2004.02.002</pub-id><?supplied-pmid 15136169?><pub-id pub-id-type="pmid">15136169</pub-id></element-citation></ref><ref id="CR10"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hobson</surname><given-names>RW</given-names></name><name><surname>Howard</surname><given-names>VJ</given-names></name><name><surname>Roubin</surname><given-names>GS</given-names></name><name><surname>Brott</surname><given-names>TG</given-names></name><name><surname>Ferguson</surname><given-names>RD</given-names></name><name><surname>Popma</surname><given-names>JJ</given-names></name><name><surname>Howard</surname><given-names>G</given-names></name></person-group><article-title>Carotid artery stenting is associated with increased complications in octogenarians: 30-Day stroke and death rates in the CREST lead-in phase</article-title><source>J Vasc Surg</source><year>2004</year><volume>40</volume><issue>6</issue><fpage>1106</fpage><lpage>1111</lpage><pub-id pub-id-type="doi">10.1016/j.jvs.2004.10.022</pub-id><?supplied-pmid 15622363?><pub-id pub-id-type="pmid">15622363</pub-id></element-citation></ref><ref id="CR11"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hruska</surname><given-names>KA</given-names></name><name><surname>Mathew</surname><given-names>S</given-names></name><name><surname>Saab</surname><given-names>G</given-names></name></person-group><article-title>Bone morphogenetic proteins in vascular calcification</article-title><source>Circulation Research</source><year>2005</year><volume>97</volume><issue>2</issue><fpage>105</fpage><lpage>114</lpage><pub-id pub-id-type="doi">10.1161/01.RES.00000175571.53833.6c</pub-id><?supplied-pmid 16037577?><pub-id pub-id-type="pmid">16037577</pub-id></element-citation></ref><ref id="CR12"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Islas</surname><given-names>J</given-names></name><name><surname>Moreno-Cuevas</surname><given-names>J</given-names></name></person-group><article-title>A microRNA perspective on cardiovascular development and diseases: an update</article-title><source>Int J Mol Sci</source><year>2018</year><volume>19</volume><issue>7</issue><fpage>2075</fpage><pub-id pub-id-type="doi">10.3390/ijms19072075</pub-id></element-citation></ref><ref id="CR13"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ito</surname><given-names>T</given-names></name><name><surname>Yagi</surname><given-names>S</given-names></name><name><surname>Yamakuchi</surname><given-names>M</given-names></name></person-group><article-title>MicroRNA-34a regulation of endothelial senescence</article-title><source>Biochemical and Biophysical Research Communications</source><year>2010</year><volume>398</volume><issue>4</issue><fpage>735</fpage><lpage>740</lpage><pub-id pub-id-type="doi">10.1016/j.bbrc.2010.07.012</pub-id><?supplied-pmid 20627091?><pub-id pub-id-type="pmid">20627091</pub-id></element-citation></ref><ref id="CR14"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kureel</surname><given-names>J</given-names></name><name><surname>Dixit</surname><given-names>M</given-names></name><name><surname>Tyagi</surname><given-names>AM</given-names></name><name><surname>Mansoori</surname><given-names>MN</given-names></name><name><surname>Srivastava</surname><given-names>K</given-names></name><name><surname>Raghuvanshi</surname><given-names>A</given-names></name><name><surname>Singh</surname><given-names>D</given-names></name></person-group><article-title>MiR-542-3p suppresses osteoblast cell proliferation and differentiation, targets BMP-7 signaling and inhibits bone formation</article-title><source>Cell Death Dis</source><year>2014</year><volume>5</volume><issue>2</issue><fpage>e1050</fpage><lpage>e1011</lpage><pub-id pub-id-type="doi">10.1038/cddis.2014.4</pub-id><?supplied-pmid 24503542?><pub-id pub-id-type="pmid">24503542</pub-id></element-citation></ref><ref id="CR15"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kusakawa</surname><given-names>Y</given-names></name><name><surname>Mikawa</surname><given-names>S</given-names></name><name><surname>Sato</surname><given-names>K</given-names></name></person-group><article-title>BMP7 expression in the adult rat brain</article-title><source>IBRO Reports</source><year>2017</year><volume>3</volume><fpage>72</fpage><lpage>86</lpage><pub-id pub-id-type="doi">10.1016/j.ibror.2017.06.002</pub-id><?supplied-pmid 30135944?><pub-id pub-id-type="pmid">30135944</pub-id></element-citation></ref><ref id="CR16"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lacolley</surname><given-names>P</given-names></name><name><surname>Regnault</surname><given-names>V</given-names></name><name><surname>Avolio</surname><given-names>AP</given-names></name></person-group><article-title>Smooth muscle cell and arterial aging: basic and clinical aspects</article-title><source>Cardiovascular Research</source><year>2018</year><volume>114</volume><issue>4</issue><fpage>513</fpage><lpage>528</lpage><pub-id pub-id-type="doi">10.1093/cvr/cvy009</pub-id><?supplied-pmid 29514201?><pub-id pub-id-type="pmid">29514201</pub-id></element-citation></ref><ref id="CR17"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lacolley</surname><given-names>P</given-names></name><name><surname>Regnault</surname><given-names>V</given-names></name><name><surname>Nicoletti</surname><given-names>A</given-names></name><name><surname>Li</surname><given-names>Z</given-names></name><name><surname>Michel</surname><given-names>JB</given-names></name></person-group><article-title>The vascular smooth muscle cell in arterial pathology: a cell that can take on multiple roles</article-title><source>Cardiovasc Res</source><year>2012</year><volume>59</volume><issue>2</issue><fpage>1171</fpage><lpage>1177</lpage><pub-id pub-id-type="doi">10.1093/cvr/cvs135</pub-id></element-citation></ref><ref id="CR18"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>X</given-names></name><name><surname>Yang</surname><given-names>H-Y</given-names></name><name><surname>Giachelli</surname><given-names>CM</given-names></name></person-group><article-title>BMP-2 promotes phosphate uptake, phenotypic modulation, and calcification of human vascular smooth muscle cells</article-title><source>Atherosclerosis</source><year>2008</year><volume>199</volume><issue>2</issue><fpage>271</fpage><pub-id pub-id-type="doi">10.1016/j.atherosclerosis.2007.11.031</pub-id><?supplied-pmid 18179800?><pub-id pub-id-type="pmid">18179800</pub-id></element-citation></ref><ref id="CR19"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liao</surname><given-names>J</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Wu</surname><given-names>Y</given-names></name><name><surname>Zeng</surname><given-names>F</given-names></name><name><surname>Shi</surname><given-names>L</given-names></name></person-group><article-title>Akt modulation by miR-145 during exercise-induced VSMC phenotypic switching in hypertension</article-title><source>Life Sciences</source><year>2018</year><volume>199</volume><fpage>71</fpage><lpage>79</lpage><pub-id pub-id-type="doi">10.1016/j.lfs.2018.03.011</pub-id><?supplied-pmid 29522767?><pub-id pub-id-type="pmid">29522767</pub-id></element-citation></ref><ref id="CR20"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>B</given-names></name><name><surname>Li</surname><given-names>J</given-names></name><name><surname>Zheng</surname><given-names>M</given-names></name><name><surname>Ge</surname><given-names>J</given-names></name><name><surname>Li</surname><given-names>J</given-names></name><name><surname>Yu</surname><given-names>P</given-names></name></person-group><article-title>MiR-542-3p exerts tumor suppressive functions in non-small cell lung cancer cells by upregulating FTSJ2</article-title><source>Life Sci</source><year>2017</year><volume>188</volume><issue>1</issue><fpage>87</fpage><lpage>95</lpage><pub-id pub-id-type="doi">10.1016/j.lfs.2017.08.018</pub-id><?supplied-pmid 28866101?><pub-id pub-id-type="pmid">28866101</pub-id></element-citation></ref><ref id="CR21"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>J</given-names></name><name><surname>Xiao</surname><given-names>X</given-names></name><name><surname>Shen</surname><given-names>Y</given-names></name><name><surname>Chen</surname><given-names>L</given-names></name><name><surname>Xu</surname><given-names>C</given-names></name><name><surname>Zhao</surname><given-names>H</given-names></name><name><surname>Zu</surname><given-names>X</given-names></name></person-group><article-title>MicroRNA-32 promotes calcification in vascular smooth muscle cells: implications as a novel marker for coronary artery calcification</article-title><source>PLoS ONE</source><year>2017</year><volume>12</volume><issue>3</issue><fpage>e0174138</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0174138</pub-id><?supplied-pmid 28319142?><pub-id pub-id-type="pmid">28319142</pub-id></element-citation></ref><ref id="CR22"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Long</surname><given-names>J</given-names></name><name><surname>Badal</surname><given-names>SS</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Chang</surname><given-names>BHJ</given-names></name><name><surname>Rodriguez</surname><given-names>A</given-names></name><name><surname>Danesh</surname><given-names>FR</given-names></name></person-group><article-title>MicroRNA-22 is a master regulator of bone morphogenetic protein-7/6 homeostasis in the kidney</article-title><source>J Biol Chem</source><year>2013</year><volume>288</volume><issue>51</issue><fpage>36202</fpage><lpage>36214</lpage><pub-id pub-id-type="doi">10.1074/jbc.M113.498634</pub-id><?supplied-pmid 24163368?><pub-id pub-id-type="pmid">24163368</pub-id></element-citation></ref><ref id="CR23"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Magenta</surname><given-names>A</given-names></name><name><surname>Cencioni</surname><given-names>C</given-names></name><name><surname>Fasanaro</surname><given-names>P</given-names></name><name><surname>Zaccagnini</surname><given-names>G</given-names></name><name><surname>Greco</surname><given-names>S</given-names></name><name><surname>Sarra-Ferraris</surname><given-names>G</given-names></name><name><surname>Capogrossi</surname><given-names>MC</given-names></name></person-group><article-title>MiR-200c is upregulated by oxidative stress and induces endothelial cell apoptosis and senescence via ZEB1 inhibition</article-title><source>Cell Death Differ</source><year>2011</year><volume>18</volume><fpage>1628</fpage><lpage>1639</lpage><pub-id pub-id-type="doi">10.1038/cdd.2011.42</pub-id><?supplied-pmid 21527937?><pub-id pub-id-type="pmid">21527937</pub-id></element-citation></ref><ref id="CR24"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mukamal</surname><given-names>KJ</given-names></name><name><surname>Kronmal</surname><given-names>RA</given-names></name><name><surname>Tracy</surname><given-names>RP</given-names></name><name><surname>Cushman</surname><given-names>M</given-names></name><name><surname>Siscovick</surname><given-names>DS</given-names></name></person-group><article-title>Traditional and novel risk factors in older adults: cardiovascular risk assessment late in life</article-title><source>Am J Geriatr Cardiol</source><year>2004</year><volume>13</volume><issue>2</issue><fpage>69</fpage><lpage>80</lpage><pub-id pub-id-type="doi">10.1111/j.1076-7460.2004.02123.x</pub-id><pub-id pub-id-type="pmid">15010653</pub-id></element-citation></ref><ref id="CR25"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Owens</surname><given-names>GK</given-names></name><name><surname>Kumar</surname><given-names>MS</given-names></name><name><surname>Wamhoff</surname><given-names>BR</given-names></name></person-group><article-title>Molecular regulation of vascular smooth muscle cell differentiation in development and disease</article-title><source>Physiol Rev</source><year>2004</year><volume>84</volume><issue>3</issue><fpage>194</fpage><lpage>204</lpage><pub-id pub-id-type="doi">10.1152/physrev.00041.2003</pub-id></element-citation></ref><ref id="CR26"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pan</surname><given-names>J</given-names></name><name><surname>Li</surname><given-names>X</given-names></name><name><surname>Wu</surname><given-names>W</given-names></name><name><surname>Xue</surname><given-names>M</given-names></name><name><surname>Hou</surname><given-names>H</given-names></name><name><surname>Zhai</surname><given-names>W</given-names></name><name><surname>Chen</surname><given-names>W</given-names></name></person-group><article-title>Long non-coding RNA UCA1 promotes cisplatin/gemcitabine resistance through CREB modulating miR-196a-5p in bladder cancer cells</article-title><source>Cancer Lett</source><year>2016</year><volume>383</volume><issue>1</issue><fpage>64</fpage><lpage>76</lpage><pub-id pub-id-type="doi">10.1016/j.canlet.2016.08.015</pub-id></element-citation></ref><ref id="CR27"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Porretti</surname><given-names>J</given-names></name><name><surname>Dalton</surname><given-names>GN</given-names></name><name><surname>Massillo</surname><given-names>C</given-names></name><name><surname>Scalise</surname><given-names>GD</given-names></name><name><surname>Farr&#x000e9;</surname><given-names>PL</given-names></name><name><surname>Elble</surname><given-names>R</given-names></name><name><surname>De Siervi</surname><given-names>A</given-names></name></person-group><article-title>CLCA2 epigenetic regulation by CTBP1, HDACs, ZEB1, EP300 and miR-196b-5p impacts prostate cancer cell adhesion and EMT in metabolic syndrome disease</article-title><source>Int J Cancer</source><year>2018</year><volume>143</volume><issue>4</issue><fpage>897</fpage><lpage>906</lpage><pub-id pub-id-type="doi">10.1002/ijc.31379</pub-id><?supplied-pmid 29536528?><pub-id pub-id-type="pmid">29536528</pub-id></element-citation></ref><ref id="CR28"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Qian</surname><given-names>DH</given-names></name><name><surname>Gao</surname><given-names>P</given-names></name><name><surname>Feng</surname><given-names>H</given-names></name><name><surname>Qin</surname><given-names>ZX</given-names></name><name><surname>Li</surname><given-names>JB</given-names></name><name><surname>Huang</surname><given-names>L</given-names></name></person-group><article-title>Down-regulation of mir-542-3p promotes neointimal formation in the aging rat</article-title><source>Vasc Pharmacol</source><year>2015</year><volume>72</volume><fpage>118</fpage><lpage>129</lpage><pub-id pub-id-type="doi">10.1016/j.vph.2015.05.010</pub-id></element-citation></ref><ref id="CR29"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roubin</surname><given-names>GS</given-names></name><name><surname>New</surname><given-names>G</given-names></name><name><surname>Iyer</surname><given-names>SS</given-names></name><name><surname>Vitek</surname><given-names>JJ</given-names></name><name><surname>Al-Mubarak</surname><given-names>N</given-names></name><name><surname>Liu</surname><given-names>MW</given-names></name><name><surname>Kuntz</surname><given-names>RE</given-names></name></person-group><article-title>Immediate and late clinical outcomes of carotid artery stenting in patients with symptomatic and asymptomatic carotid artery stenosis: a 5-year prospective analysis</article-title><source>Circulation</source><year>2001</year><volume>103</volume><issue>4</issue><fpage>532</fpage><lpage>537</lpage><pub-id pub-id-type="doi">10.1161/01.CIR.103.4.532</pub-id><?supplied-pmid 11157718?><pub-id pub-id-type="pmid">11157718</pub-id></element-citation></ref><ref id="CR30"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tao</surname><given-names>J</given-names></name><name><surname>Liu</surname><given-names>Z</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Wang</surname><given-names>L</given-names></name><name><surname>Yao</surname><given-names>B</given-names></name><name><surname>Li</surname><given-names>Q</given-names></name><name><surname>Liu</surname><given-names>Q</given-names></name></person-group><article-title>MiR-542-3p inhibits metastasis and epithelial-mesenchymal transition of hepatocellular carcinoma by targeting UBE3C</article-title><source>Biomed Pharmacother</source><year>2017</year><volume>93</volume><fpage>420</fpage><lpage>428</lpage><pub-id pub-id-type="doi">10.1016/j.biopha.2017.06.070</pub-id><?supplied-pmid 28666208?><pub-id pub-id-type="pmid">28666208</pub-id></element-citation></ref><ref id="CR31"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vallot</surname><given-names>O</given-names></name><name><surname>Combettes</surname><given-names>L</given-names></name><name><surname>Jourdon</surname><given-names>P</given-names></name><name><surname>Inamo</surname><given-names>J</given-names></name><name><surname>Marty</surname><given-names>I</given-names></name><name><surname>Claret</surname><given-names>M</given-names></name><name><surname>Lompr&#x000e9;</surname><given-names>AM</given-names></name></person-group><article-title>Intracellular Ca(2+) handling in vascular smooth muscle cells is affected by proliferation</article-title><source>Arterioscler Thromb Vasc Biol</source><year>2000</year><volume>20</volume><issue>5</issue><fpage>1225</fpage><lpage>1235</lpage><pub-id pub-id-type="doi">10.1161/01.ATV.20.5.1225</pub-id><?supplied-pmid 10807737?><pub-id pub-id-type="pmid">10807737</pub-id></element-citation></ref><ref id="CR32"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>TM</given-names></name><name><surname>Chen</surname><given-names>KC</given-names></name><name><surname>Hsu</surname><given-names>PY</given-names></name><name><surname>Lin</surname><given-names>HF</given-names></name><name><surname>Wang</surname><given-names>YS</given-names></name><name><surname>Chen</surname><given-names>CY</given-names></name><name><surname>Juo</surname><given-names>SHH</given-names></name></person-group><article-title>microRNA let-7g suppresses PDGF-induced conversion of vascular smooth muscle cell into the synthetic phenotype</article-title><source>J Cell Mol Med</source><year>2017</year><volume>21</volume><issue>12</issue><fpage>3592</fpage><lpage>3601</lpage><pub-id pub-id-type="doi">10.1111/jcmm.13269</pub-id><?supplied-pmid 28699690?><pub-id pub-id-type="pmid">28699690</pub-id></element-citation></ref><ref id="CR33"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wojciechowska</surname><given-names>A</given-names></name><name><surname>Osiak</surname><given-names>A</given-names></name><name><surname>Kozar-Kami&#x00144;ska</surname><given-names>K</given-names></name></person-group><article-title>MicroRNA in cardiovascular biology and disease</article-title><source>Adv Clin Exp Med</source><year>2017</year><volume>26</volume><issue>5</issue><fpage>868</fpage><lpage>874</lpage><pub-id pub-id-type="doi">10.17219/acem/62915</pub-id></element-citation></ref><ref id="CR34"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>C</given-names></name><name><surname>Zheng</surname><given-names>Z</given-names></name><name><surname>Ren</surname><given-names>W</given-names></name><name><surname>Deng</surname><given-names>T</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Yang</surname><given-names>L</given-names></name><name><surname>Guo</surname><given-names>L</given-names></name></person-group><article-title>Mm9_circ_009056 enhances osteogenesis by targeting BMP7 via CGRP-mediated miR-22&#x02013;3p</article-title><source>Biochemical and Biophysical Research Communications</source><year>2018</year><volume>501</volume><issue>1</issue><fpage>199</fpage><lpage>205</lpage><pub-id pub-id-type="doi">10.1016/j.bbrc.2018.04.215</pub-id><?supplied-pmid 29709471?><pub-id pub-id-type="pmid">29709471</pub-id></element-citation></ref><ref id="CR35"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yamaguchi</surname><given-names>A</given-names></name><name><surname>Sakamoto</surname><given-names>K</given-names></name><name><surname>Minamizato</surname><given-names>T</given-names></name><name><surname>Katsube</surname><given-names>K</given-names></name><name><surname>Nakanishi</surname><given-names>S</given-names></name></person-group><article-title>Regulation of osteoblast differentiation mediated by BMP, Notch, and CCN3/NOV</article-title><source>Japanese Dent Sci Rev</source><year>2008</year><volume>44</volume><issue>1</issue><fpage>48</fpage><lpage>56</lpage><pub-id pub-id-type="doi">10.1016/j.jdsr.2007.11.003</pub-id></element-citation></ref><ref id="CR36"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>F</given-names></name><name><surname>Chen</surname><given-names>Q</given-names></name><name><surname>He</surname><given-names>S</given-names></name><name><surname>Yang</surname><given-names>M</given-names></name><name><surname>Maguire</surname><given-names>EM</given-names></name><name><surname>An</surname><given-names>W</given-names></name><name><surname>Xiao</surname><given-names>Q</given-names></name></person-group><article-title>miRNA-22 is a novel mediator of vascular smooth muscle cell phenotypic modulation and neointima formation</article-title><source>Circulation</source><year>2017</year><volume>137</volume><issue>17</issue><fpage>1824</fpage><lpage>1841</lpage><pub-id pub-id-type="doi">10.1161/CIRCULATIONAHA.117.027799</pub-id><?supplied-pmid 29246895?><pub-id pub-id-type="pmid">29246895</pub-id></element-citation></ref><ref id="CR37"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>JP</given-names></name><name><surname>Yang</surname><given-names>JK</given-names></name><name><surname>Li</surname><given-names>C</given-names></name><name><surname>Cui</surname><given-names>ZQ</given-names></name><name><surname>Liu</surname><given-names>HJ</given-names></name><name><surname>Sun</surname><given-names>XF</given-names></name><name><surname>Jiao</surname><given-names>BH</given-names></name></person-group><article-title>Downregulation of ZMYND11 induced by miR-196a-5p promotes the progression and growth of GBM</article-title><source>Biochem Biophys Res Commun</source><year>2017</year><volume>494</volume><issue>3&#x02013;4</issue><fpage>674</fpage><lpage>680</lpage><pub-id pub-id-type="doi">10.1016/j.bbrc.2017.10.098</pub-id><?supplied-pmid 29066350?><pub-id pub-id-type="pmid">29066350</pub-id></element-citation></ref><ref id="CR38"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yao</surname><given-names>Y</given-names></name><name><surname>Bennett</surname><given-names>BJ</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Rosenfeld</surname><given-names>ME</given-names></name><name><surname>Giachelli</surname><given-names>C</given-names></name><name><surname>Lusis</surname><given-names>AJ</given-names></name><name><surname>Bostr&#x000f6;m</surname><given-names>KI</given-names></name></person-group><article-title>Inhibition of bone morphogenetic proteins protects against atherosclerosis and vascular calcification</article-title><source>Circulation Research</source><year>2010</year><volume>107</volume><issue>4</issue><fpage>485</fpage><lpage>494</lpage><pub-id pub-id-type="doi">10.1161/CIRCRESAHA.110.219071</pub-id><?supplied-pmid 20576934?><pub-id pub-id-type="pmid">20576934</pub-id></element-citation></ref><ref id="CR39"><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname><given-names>YG</given-names></name><name><surname>Meng</surname><given-names>FX</given-names></name><name><surname>Li</surname><given-names>BW</given-names></name><name><surname>Sheng</surname><given-names>YM</given-names></name><name><surname>Liu</surname><given-names>MM</given-names></name><name><surname>Wang</surname><given-names>B</given-names></name><name><surname>Xiu</surname><given-names>RJ</given-names></name></person-group><article-title>Gelatinases promote calcification of vascular smooth muscle cells by up-regulating bone morphogenetic protein-2</article-title><source>Biochem Biophys Res Commun</source><year>2016</year><volume>470</volume><issue>2</issue><fpage>287</fpage><lpage>293</lpage><pub-id pub-id-type="doi">10.1016/j.bbrc.2016.01.067</pub-id><?supplied-pmid 26797522?><pub-id pub-id-type="pmid">26797522</pub-id></element-citation></ref><ref id="CR40"><label>40.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>J</given-names></name><name><surname>Wang</surname><given-names>K-C</given-names></name><name><surname>Wu</surname><given-names>W</given-names></name><name><surname>Subramaniam</surname><given-names>S</given-names></name><name><surname>Shyy</surname><given-names>JY-J</given-names></name><name><surname>Chiu</surname><given-names>J-J</given-names></name><name><surname>Chien</surname><given-names>S</given-names></name></person-group><article-title>MicroRNA-21 targets peroxisome proliferators-activated receptor- in an autoregulatory loop to modulate flow-induced endothelial inflammation</article-title><source>Proc Natl Acad Scinces</source><year>2011</year><volume>108</volume><issue>25</issue><fpage>10355</fpage><lpage>10360</lpage><pub-id pub-id-type="doi">10.1073/pnas.1107052108</pub-id></element-citation></ref></ref-list></back></article>